MedTrace Logo

Pilot Trial of the Body Image Program to Prevent Eating Disorders in Female University Students in Mexico

NCT07193043 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-09-25

No results posted yet for this study

Summary

The goal of this clinical trial is to examine whether the Body Image Program (BIP), a group workshop, is feasible and acceptable to deliver to young women in Mexico. The program is designed to help participants critically evaluate social pressures to be thin and to support healthier body attitudes.

The main questions are:

* Can the investigators successfully recruit, retain, and engage university students in the program?
* Do participants find the program useful and clear?
* Does the program show early indications of lowering body dissatisfaction and unhealthy eating attitudes?

Participants will:

* Attend 2 group sessions, one per week, each lasting approximately 2 hours (120 minutes).
* Complete short activities and homework exercises between sessions, such as reflective writing or self-affirmation tasks.
* Complete questionnaires at baseline, immediately after the program, and at 1-month follow-up.

Conditions

Interventions

BEHAVIORAL

Body Image Program (BIP)

The Body Image Program (BIP) is a culturally adapted, dissonance-based group intervention derived from the Body Project. It is delivered in two weekly sessions of 120 minutes each, in small groups of 7-10 participants, by trained health professionals with experience in eating disorders. Activities include verbal, written, and behavioral exercises to critique sociocultural appearance ideals, reduce thin-ideal internalization, and promote more adaptive body image. Each session ends with homework: after Session 1, tasks include a behavioral challenge and reflective writing; after Session 2, a commitment activity (e.g., self-affirmation or body activism) is completed within one week and submitted by email. Participants in the waitlist control arm complete the same assessments but receive the BIP between weeks 6 and 8, after the final follow-up.

Sponsors & Collaborators

  • Comenzar de Nuevo, AC

    lead OTHER

Principal Investigators

  • Eva Trujillo-ChiVacuán, MD · Comenzar de Nuevo, AC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07193043 on ClinicalTrials.gov